Cytokines and HCV-related disorders

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Fallahi, Poupak ^a   Ferri, Clodoveo ^b   Ferrari, Silvia Martina ^a   Corrado, Alda ^a   Sansonno, Domenico ^c   Antonelli, Alessandro ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD4 ANTIGEN; CD8 ANTIGEN; CX3C CHEMOKINE; CXCL11 CHEMOKINE; CXCL3 CHEMOKINE; CXCL9 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 18; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PLATELET DERIVED GROWTH FACTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ADAPTIVE IMMUNITY; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CRYOGLOBULINEMIA; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DISEASE ASSOCIATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INFECTION CONTROL; INFLAMMATORY INFILTRATE; INNATE IMMUNITY; LIVER CIRRHOSIS; LIVER INJURY; LIVER PARENCHYMA; LYMPHOPROLIFERATIVE DISEASE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; TH0 CELL; TH1 CELL; TH17 CELL; TH2 CELL; ANIMAL; DRUG EFFECT; IMMUNE EVASION; IMMUNITY; IMMUNOLOGY; TH1 TH2 BALANCE; VIRUS LOAD;

ANIMALS; AUTOIMMUNITY; CYTOKINES; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNE EVASION; IMMUNITY; INTERFERON-ALPHA; LIVER CIRRHOSIS; TH1-TH2 BALANCE; VIRAL LOAD;

EID: 84862271549     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/468107     Document Type: Review

References (119)

1. Steinke J. W., Borish L., Cytokines and chemokines Journal of Allergy and Clinical Immunology 2006 117 2, supplement S441 S445
2. Fernandez E. J., Lolis E., Structure, function, and inhibition of chemokines Annual Review of Pharmacology and Toxicology 2002 42 469 499 (Pubitemid 34160533)
3. Murphy P. M., Baggiolini M., Charo I. F., Hebert C. A., Horuk R., Matsushima K., Miller L. H., Oppenheim J. J., Power C. A., International union of pharmacology. XXII. Nomenclature for chemokine receptors Pharmacological Reviews 2000 52 1 145 176 (Pubitemid 30127598)
4. Zlotnik A., Yoshie O., Chemokines: a new classification system and their role in immunity Immunity 2000 12 2 121 127 (Pubitemid 30398626)
5. Horuk R., Chemokine receptors Cytokine and Growth Factor Reviews 2001 12 4 313 335 (Pubitemid 32851745)
6. Lauer G. M., Walker B. D., Hepatitis C virus infection The New England Journal of Medicine 2001 345 1 41 52 (Pubitemid 32634271)
7. Ganem D., Prince A. M., Hepatitis B virus infectionnatural history and clinical consequences The New England Journal of Medicine 2004 350 11 1118 1129 (Pubitemid 38298992)
8. Su A. I., Pezacki J. P., Wodicka L., Brideau A. D., Supekova L., Thimme R., Wieland S., Bukh J., Purcell R. H., Schultz P. G., Chisari F. V., Genomic analysis of the host response to hepatitis C virus infection Proceedings of the National Academy of Sciences of the United States of America 2002 99 24 15669 15674 (Pubitemid 35403989)
9. Guidotti L. G., Chisari F. V., Noncytolytic control of viral infections by the innate and adaptive immune response Annual Review of Immunology 2001 19 65 91 (Pubitemid 32368030)
10. Moretta A., Natural killer cells and dendritic cells: rendezvous in abused tissues Nature Reviews Immunology 2002 2 12 957 964 (Pubitemid 37323216)
11. Marcenaro E., Della Chiesa M., Bellora F., Parolini S., Millo R., Moretta L., Moretta A., IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors Journal of Immunology 2005 174 7 3992 3998 (Pubitemid 40395974)
12. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y. J., Pulendran B., Palucka K., Immunobiology of dendritic cells Annual Review of Immunology 2000 18 767 811 (Pubitemid 30365397)
13. Charo I. F., Ransohoff R. M., Mechanisms of disease: the many roles of chemokines and chemokine receptors in inflammation The New England Journal of Medicine 2006 354 6 610 621 (Pubitemid 43209108)
14. Shields P. L., Morland C. M., Salmon M., Qin S., Hubscher S. G., Adams D. H., Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver Journal of Immunology 1999 163 11 6236 6243
15. Maini M. K., Boni C., Ogg G. S., King A. S., Reignat S., Chun Kyon Lee, Larrubia J. R., Webster G. J. M., McMichael A. J., Ferrari C., Williams R., Vergani D., Bertoletti A., Direct ex vivo analysis of hepatitis B virus-specific CD8 + T cells associated with the control of infection Gastroenterology 1999 117 6 1386 1396
16. Lauer G. M., Barnes E., Lucas M., Timm J., Ouchi K., Kim A. Y., Day C. L., Robbins G. K., Casson D. R., Reiser M., Dusheiko G., Allen T. M., Chung R. T., Walker B. D., Klenerman P., High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection Gastroenterology 2004 127 3 924 936 (Pubitemid 39208424)
17. Maini M. K., Boni C., Lee C. K., Larrubia J. R., Reignat S., Ogg G. S., King A. S., Herberg J., Gilson R., Alisa A., Williams R., Vergani D., Naoumov N. V., Ferrari C., Bertoletti A., The role of virus-specific CD8 + cells in liver damage and viral control during persistent hepatitis B virus infection Journal of Experimental Medicine 2000 191 8 1269 1280 (Pubitemid 30227116)
18. Guidotti L. G., Chisari F. V., Immunobiology and pathogenesis of viral hepatitis Annual Review of Pathology 2006 1 23 61
19. Samuel C. E., Antiviral actions of interferons Clinical Microbiology Reviews 2001 14 4 778 809 (Pubitemid 32979631)
20. Bigger C. B., Guerra B., Brasky K. M., Hubbard G., Beard M. R., Luxon B. A., Lemon S. M., Lanford R. E., Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees Journal of Virology 2004 78 24 13779 13792 (Pubitemid 39612775)
21. Polyak S. J., Khabar K. S. A., Paschal D. M., Ezelle H. J., Duverlie G., Barber G. N., Levy D. E., Mukaida N., Gretch D. R., Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response Journal of Virology 2001 75 13 6095 6106 (Pubitemid 32553140)
22. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., Fujita T., The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses Nature Immunology 2004 5 7 730 737 (Pubitemid 39023305)
23. Rebsamen M., Meylan E., Curran J., Tschopp J., The antiviral adaptor proteins Cardif and Trif are processed and inactivated by caspases Cell Death and Differentiation 2008 15 11 1804 1811
24. Biron C. A., Nguyen K. B., Pien G. C., Cousens L. P., Salazar-Mather T. P., Natural killer cells in antiviral defense: function and regulation by innate cytokines Annual Review of Immunology 1999 17 189 220 (Pubitemid 29241123)
25. Thimme R., Wieland S., Steiger C., Ghrayeb J., Reimann K. A., Purcell R. H., Chisari F. V., CD8 + T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection Journal of Virology 2003 77 1 68 76 (Pubitemid 36004947)
26. Tseng C. T. K., Klimpel G. R., Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions Journal of Experimental Medicine 2002 195 1 43 49 (Pubitemid 34074495)
27. Ulsenheimer A., Gerlach J. T., Jung M. C., Gruener N., Wchtler M., Backmund M., Santantonio T., Schraut W., Heeg M. H. J., Schirren C. A., Zachoval R., Pape G. R., Diepolder H. M., Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection Hepatology 2005 41 3 643 651 (Pubitemid 40292058)
28. Anthony D. D., Yonkers N. L., Post A. B., Asaad R., Heinzel F. P., Lederman M. M., Lehmann P. V., Valdez H., Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection Journal of Immunology 2004 172 8 4907 4916 (Pubitemid 38456415)
29. Szabo G., Dolganiuc A., Subversion of plasmacytoid and myeloid dendritic cell functions in chronic HCV infection Immunobiology 2005 210 24 237 247 (Pubitemid 41025165)
30. Bellecave P., Moradpour D., A fresh look at interferon-alpha signaling and treatment outcomes in chronic hepatitis C Hepatology 2008 48 4 1330 1333
31. Kanto T., Inoue M., Miyazaki M., Itose I., Miyatake H., Sakakibara M., Yakushijin T., Kaimori A., Oki C., Hiramatsu N., Kasahara A., Hayashi N., Impaired function of dendritic cells circulating in patients infected with hepatitis C virus who have persistently normal alanine aminotransferase levels Intervirology 2006 49 1-2 58 63 (Pubitemid 41318177)
32. Napoli J., Bishop G. A., Mcguinness P. H., Painter D. M., Mccaughan G. W., Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines Hepatology 1996 24 4 759 765 (Pubitemid 26334270)
33. Bertoletti A., D'Elios M. M., Boni C., De Carli M., Zignego A. L., Durazzo M., Missale G., Penna A., Fiaccadori F., Del Prete G., Ferrari C., Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections Gastroenterology 1997 112 1 193 199 (Pubitemid 27009002)
34. Moser M., Murphy K. M., Dendritic cell regulation of TH1-TH2 development Nature Immunology 2000 1 3 199 205
35. Day C. L., Lauer G. M., Robbins G. K., McGovern B., Wurcel A. G., Gandhi R. T., Chung R. T., Walker B. D., Broad specificity of virus-specific CD4 + T-helper-cell responses in resolved hepatitis C virus infection Journal of Virology 2002 76 24 12584 12595 (Pubitemid 35386944)
36. Rosen H. R., Miner C., Sasaki A. W., Lewinsohn D. M., Conrad A. J., Bakke A., Bouwer H. G. A., Hinrichs D. J., Frequencies of HCV-specific effector CD4 + T cells by flow cytometry: correlation with clinical disease stages Hepatology 2002 35 1 190 198 (Pubitemid 34032560)
37. Thimme R., Oldach D., Chang K. M., Steiger C., Ray S. C., Chisari F. V., Determinants of viral clearance and persistence during acute hepatitis C virus infection Journal of Experimental Medicine 2001 194 10 1395 1406 (Pubitemid 33081515)
38. Franzese O., Kennedy P. T. F., Gehring A. J., Gotto J., Williams R., Maini M. K., Bertoletti A., Modulation of the CD8 + -T-cell response by CD4 + CD25 + regulatory T cells in patients with hepatitis B virus infection Journal of Virology 2005 79 6 3322 3328 (Pubitemid 40327921)
39. Larrubia J. R., Benito-Martnez S., Calvino M., Sanz-de-Villalobos E., Parra-Cid T., Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection World Journal of Gastroenterology 2008 14 47 7149 7159
40. Larrubia J. R., Calvino M., Benito S., Sanz-de-Villalobos E., Perna C., Pérez-Hornedo J., Gonzlez-Mateos F., Garca-Garzn S., Bienvenido A., Parra T., The role of CCR5/CXCR3 expressing CD8 + cells in liver damage and viral control during persistent hepatitis C virus infection Journal of Hepatology 2007 47 5 632 641 (Pubitemid 47503421)
41. Kakimi K., Lane T. E., Wieland S., Asensio V. C., Campbell I. L., Chisari F. V., Guidotti L. G., Blocking chemokine responsive to -2/interferon (IFN)- inducible protein and monokine induced by IFN- activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes Journal of Experimental Medicine 2001 194 12 1755 1766 (Pubitemid 34028655)
42. Taub R., Greenbaum L. E., Peng Y., Transcriptional regulatory signals define cytokine-dependent andindependent pathways in liver regeneration Seminars in Liver Disease 1999 19 2 117 128 (Pubitemid 29326119)
43. Ramadori G., Saile B., Inflammation, damage repair, immune cells, and liver fibrosis: specific or nonspecific, this is the question Gastroenterology 2004 127 3 997 1000 (Pubitemid 39208434)
44. Ferri C., Zignego A. L., Relation between infection and autoimmunity in mixed cryoglobulinemia Current Opinion in Rheumatology 2000 12 1 53 60 (Pubitemid 30036688)
45. Zignego A. L., Ferri C., Giannelli F., Giannini C., Caini P., Monti M., Marrocchi M. E., Di Pietro E., La Villa G., Laffi G., Gentilini P., Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas Annals of Internal Medicine 2002 137 7 571 580
46. Wong V. S., Egner W., Elsey T., Brown D., Alexander G. J. M., Incidence, character and clinical relevance of mixed cryoglobulinaemia in patients with chronic hepatitis C virus infection Clinical and Experimental Immunology 1996 104 1 25 31 (Pubitemid 26103408)
47. Pileri P., Uematsu Y., Campagnoli S., Galli G., Falugi F., Petracca R., Weiner A. J., Houghton M., Rosa D., Grandi G., Abrignani S., Binding of hepatitis C virus to CD81 Science 1998 282 5390 938 941 (Pubitemid 28507525)
48. De Re V., De Vita S., Marzotto A., Gloghini A., Pivetta B., Gasparotto D., Cannizzaro R., Carbone A., Boiocchi M., Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process International Journal of Cancer 2000 87 2 211 216 (Pubitemid 30434347)
49. Sansonno D., Lauletta G., Nisi L., Gatti P., Pesola F., Pansini N., Dammacco F., Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia Clinical and Experimental Immunology 2003 133 2 275 282 (Pubitemid 36918603)
50. Ferri C., Pileri S., Zignego AL., Goedert J., Hepatitis C virus infection and non-Hodgkins lymphoma Infectious Causes of Cancer. Targets for Intervention 2000 Totowa, NJ, USA The Human Press 349 368
51. Zignego A. L., Giannelli F., Marrocchi M. E., Mazzocca A., Ferri C., Giannini C., Monti M., Caini P., La Villa G., Laffi G., Gentilini P., T(14;18) translocation in chronic hepatitis C virus infection Hepatology 2000 31 2 474 479 (Pubitemid 30078615)
52. Giannelli F., Moscarella S., Giannini C., Caini P., Monti M., Gragnani L., Romanelli R. G., Solazzo V., Laffi G., La Villa G., Gentilini P., Zignego A. L., Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation Blood 2003 102 4 1196 1201 (Pubitemid 36988022)
53. Sansonno D., Carbone A., De Re V., Dammacco F., Hepatitis C virus infection, cryoglobulinaemia, and beyond Rheumatology 2007 46 4 572 578 (Pubitemid 46523298)
54. Sne D., Limal N., Ghillani-Dalbin P., Saadoun D., Piette J. C., Cacoub P., Hepatitis C virus-associated B-cell proliferationthe role of serum B lymphocyte stimulator (BLyS/BAFF) Rheumatology 2007 46 1 65 69 (Pubitemid 44932786)
55. Fabris M., Quartuccio L., Sacco S., De Marchi G., Pozzato G., Mazzaro C., Ferraccioli G., Migone T. S., De Vita S., B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection Rheumatology 2007 46 1 37 43 (Pubitemid 44932781)
56. Sansonno D., Tucci F. A., Troiani L., Lauletta G., Montrone M., Conteduca V., Sansonno L., Dammacco F., Increased serum levels of the chemokine CXCL13 and up-regulation of its gene expression are distinctive features of HCV-related cryoglobulinemia and correlate with active cutaneous vasculitis Blood 2008 112 5 1620 1627
57. Saadoun D., Boyer O., Trébeden-Ngre H., Limal N., Bon-Durand V., Andreu M., Klatzmann D., Piette J. C., Cacoub P., Predominance of type 1 (Th1) cytokine production in the liver of patients with HCV-associated mixed cryoglobulinemia vasculitis Journal of Hepatology 2004 41 6 1031 1037 (Pubitemid 39575672)
58. Loffreda S., Muratori P., Muratori L., Mele L., Bianchi F. B., Lenzi M., Enhanced monocyte Th1 cytokine production in HCV-infected cryoglobulinemic patients Journal of Hepatology 2003 38 2 230 236 (Pubitemid 36169634)
59. Patzwahl R., Meire V., Ramadori G., Mihm S., Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization Journal of Virology 2001 75 3 1332 1338 (Pubitemid 32097955)
60. Mihm S., Schweyer S., Ramadori G., Expression of the chemokine IP-10 correlates with the accumulation of hepatic IFN- and IL-18 mRNA in chronic hepatitis C but not in hepatitis B Journal of Medical Virology 2003 70 4 562 570 (Pubitemid 36734720)
61. Matskevich A. A., Strayer D. S., Exploiting hepatitis C virus activation of NFkappaB to deliver HCV-responsive expression of interferons alpha and gamma Gene Therapy 2003 10 22 1861 1873 (Pubitemid 37258633)
62. Murata M., Nabeshima S., Maeda N., Nakashima H., Kashiwagi S., Hayashi J., Increased frequency of IFN- -producing peripheral CD8 + T cells with memory-phenotype in patients with chronic hepatitis C Journal of Medical Virology 2002 67 2 162 170 (Pubitemid 34493430)
63. Itoh Y., Morita A., Nishioji K., Narumi S., Toyama T., Daimon Y., Nakamura H., Kirishima T., Okanoue T., Clinical significance of elevated serum interferon-inducible protein-10 levels in hepatitis C virus carriers with persistently normal serum transaminase levels Journal of Viral Hepatitis 2001 8 5 341 348 (Pubitemid 34205887)
64. Antonelli A., Ferri C., Ferrari S. M., Colaci M., Fallahi P., Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia Autoimmunity Reviews 2008 8 1 18 23
65. Antonelli A., Ferri C., Galeazzi M., Giannitti C., Manno D., Mieli-Vergani G., Menegatti E., Olivieri I., Puoti M., Palazzi C., Roccatello D., Vergani D., Sarzi-Puttini P., Atzeni F., HCV infection: pathogenesis, clinical manifestations and therapy Clinical and Experimental Rheumatology 2008 26 1, supplement S39 S47
66. Antonelli A., Ferri C., Fallahi P., Hepatitis C: thyroid dysfunction in patients with hepatitis C on IFN- therapy Nature Reviews Gastroenterology and Hepatology 2009 6 11 633 635
67. Apolinario A., Majano P. L., Lorente R., Nez O., Clemente G., Garca-Monzn C., Gene expression profile of T-cell-specific chemokines in human hepatocyte-derived cells: evidence for a synergistic inducer effect of cytokines and hepatitis C virus proteins Journal of Viral Hepatitis 2005 12 1 27 37 (Pubitemid 40188771)
68. Antonelli A., Rotondi M., Fallahi P., Romagnani P., Ferrari S. M., Buonamano A., Ferrannini E., Serio M., High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism Journal of Clinical Endocrinology and Metabolism 2004 89 11 5496 5499 (Pubitemid 39518431)
69. Antonelli A., Fallahi P., Ferrari S. M., Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. Modern Rheumatology. In press
70. Antonelli A., Ferri C., Ferrari S. M., High serum levels of CXCL11 in mixed cryoglobulinemia are associated with increased circulating levels of interferon- The Journal of Rheumatology 2011 38 9 1947 1952
71. Antonelli A., Ferri C., Ferrari S. M., De Marco S., Di Domenicantonio A., Centanni M., Pupilli C., Villa E., Menichetti F., Fallahi P., Interleukin-1, C-X-C motif ligand 10, and interferon-gamma serum levels in mixed cryoglobulinemia with or without autoimmune thyroiditis Journal of Interferon and Cytokine Research 2010 30 11 835 842
72. Antonelli A., Ferri C., Ferrari S. M., Ghiri E., Marchi S., Sebastiani M., Fallahi P., Serum concentrations of interleukin 1, CXCL10, and interferon- in mixed cryoglobulinemia associated with hepatitis C infection Journal of Rheumatology 2010 37 1 91 97
73. Antonelli A., Ferri C., Fallahi P., Ferrari S. M., Sebastiani M., Ferrari D., Giunti M., Frascerra S., Tolari S., Franzoni F., Galetta F., Marchi S., Ferrannini E., High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection American Journal of Gastroenterology 2008 103 10 2488 2494
74. Antonelli A., Ferri C., Fallahi P., Ferrari S. M., Frascerra S., Franzoni F., Galetta F., Zignego A. L., Ferrannini E., CXCL10 and CCL2 serum levels in patients with mixed cryoglobulinaemia and hepatitis C Digestive and Liver Disease 2009 41 1 42 48
75. Antonelli A., Ferri C., Ferrari S. M., Ghiri E., Goglia F., Pampana A., Bruschi F., Fallahi P., Serum levels of proinflammatory cytokines interleukin-1, interleukin-6, and tumor necrosis factor in mixed cryoglobulinemia Arthritis and Rheumatism 2009 60 12 3841 3847
76. Antonelli A., Ferri C., Fallahi P., Ferrari S. M., Ghinoi A., Rotondi M., Ferrannini E., Thyroid disorders in chronic hepatitis C virus infection Thyroid 2006 16 6 563 572 (Pubitemid 44066263)
77. Antonelli A., Ferri C., Fallahi P., Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia QJM: An International Journal of Medicine 2004 97 8 499 506 (Pubitemid 39144597)
78. Antonelli A., Ferri C., Pampana A., Fallahi P., Nesti C., Pasquini M., Marchi S., Ferrannini E., Thyroid disorders in chronic hepatitis C American Journal of Medicine 2004 117 1 10 13 (Pubitemid 38798015)
79. Antonelli A., Ferri C., Fallahi P., Thyroid cancer in patients with hepatitis C infection Journal of the American Medical Association 1999 281 17 1588 (Pubitemid 29211765)
80. Antonelli A., Ferri C., Fallahi P., Pampana A., Ferrari S. M., Barani L., Marchi S., Ferrannini E., Thyroid cancer in HCV-related chronic hepatitis patients: A case-control study Thyroid 2007 17 5 447 451 (Pubitemid 46878847)
81. Prummel M. F., Laurberg P., Interferon- and autoimmune thyroid disease Thyroid 2003 13 6 547 551
82. Lenzi M., Johnson P. J., McFarlane I. G., Ballardini G., Smith H. M., McFarlane B. M., Bridger C., Vergani D., Bianchi F. B., Williams R., Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity The Lancet 1991 338 8762 277 280
83. Prentice L. M., Phillips D. I. W., Sarsero D., Beever K., McLachlan S. M., Smith B. R., Geographical distribution of subclinical autoimmune thyroid disease in Britain: a study using highly sensitive direct assays for autoantibodies to thyroglobulin and thyroid peroxidase Acta Endocrinologica 1990 123 5 493 498
84. McFarlane I. G., Autoimmunity and hepatotropic viruses Seminars in Liver Disease 1991 11 3 223 233
85. Minelli R., Braverman L. E., Giuberti T., Schianchi C., Gardini E., Salvi M., Fiaccadori F., Ugolotti G., Roti E., Effects of excess iodine administration on thyroid function in euthyroid patients with a previous episode of thyroid dysfunction induced by interferon-alpha treatment Clinical Endocrinology 1997 47 3 357 361 (Pubitemid 27395969)
86. Antonelli A., Rotondi M., Fallahi P., Romagnani P., Ferrari S. M., Paolicchi A., Ferrannini E., Serio M., Increase of interferon- inducible chemokine CXCL10 but not chemokine CCL2 serum levels in chronic autoimmune thyroiditis European Journal of Endocrinology 2005 152 2 171 177 (Pubitemid 40309561)
87. Antonelli A., Rotondi M., Ferrari S. M., Fallahi P., Romagnani P., Franceschini S. S., Serio M., Ferrannini E., Interferon- -inducible -chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor- agonists Journal of Clinical Endocrinology and Metabolism 2006 91 2 614 620 (Pubitemid 43236933)
88. Gowans E. J., Distribution of markers of hepatitis C virus infection throughout the body Seminars in Liver Disease 2000 20 1 85 102 (Pubitemid 30421411)
89. Bartolomé J., Rodrguez-Iigo E., Quadros P., Vidal S., Pascual-Miguelaez I., Rodrguez-Montes J. A., Garca-Sancho L., Carreo V., Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection Journal of Medical Virology 2008 80 9 1588 1594
90. Antonelli A., Ferri C., Fallahi P., Ferrari S. M., Frascerra S., Sebastiani M., Franzoni F., Galetta F., Ferrannini E., High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis Cytokine 2008 42 1 137 143
91. Antonelli A., Ferri C., Fallahi P., Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis Metabolism 2008 57 9 1270 1277
92. Antonelli A., Ferri C., Ferrari S. M., The presence of autoimmune thyroiditis in mixed cryoglobulinemia patients is associated with high levels of circulating interleukin-6, but not of tumor necrosis factor-alpha Clinical and Experimental Rheumatology 2011 29 1, supplement 64 S17 S22
93. Noto H., Raskin P., Hepatitis C infection and diabetes Journal of Diabetes and its Complications 2006 20 2 113 120
94. Antonelli A., Ferri C., Fallahi P., Sebastiani M., Nesti C., Barani L., Barale R., Ferrannini E., Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients Rheumatology 2004 43 2 238 240 (Pubitemid 38219683)
95. Antonelli A., Ferri C., Fallahi P., Pampana A., Ferrari S. M., Goglia F., Ferrannini E., Hepatitis C virus infection: evidence for an association with type 2 diabetes Diabetes Care 2005 28 10 2548 2550 (Pubitemid 41384312)
96. Mehta S. H., Brancati F. L., Sulkowski M. S., Strathdee S. A., Szklo M., Thomas D. L., Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States Annals of Internal Medicine 2000 133 8 592 599
97. Mehta S. H., Brancati F. L., Strathdee S. A., Pankow J. S., Netski D., Coresh J., Szklo M., Thomas D. L., Hepatitis C virus infection and incident type 2 diabetes Hepatology 2003 38 1 50 56 (Pubitemid 36775795)
98. Tanaka H., Shiota G., Kawasaki H., Changes in glucose tolerance after interferon- therapy in patients with chronic hepatitis C Journal of Medicine 1997 28 5-6 335 346 (Pubitemid 28168523)
99. Giordanino C., Bugianesi E., Smedile A., Ciancio A., Abate M. L., Olivero A., Pellicano R., Cassader M., Gambino R., Bo S., Ciccone G., Rizzetto M., Saracco G., Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study American Journal of Gastroenterology 2008 103 10 2481 2487
100. Masini M., Campani D., Boggi U., Hepatitis C virus infection and human pancreatic beta-cell dysfunction Diabetes Care 2005 28 4 940 941 (Pubitemid 40434503)
101. Gale E. A. M., Latent autoimmune diabetes in adults: a guide for the perplexed Diabetologia 2005 48 11 2195 2199 (Pubitemid 41618905)
102. Skowroski M., Zozuliska D., Juszczyk J., Wierusz-Wysocka B., Hepatitis C virus infection: evidence for an association with type 2 diabetes: response to Antonelli et al Diabetes Care 2006 29 3 750 (Pubitemid 44115403)
103. Antonelli A., Tuomi T., Nannipieri M., Fallahi P., Nesti C., Okamoto H., Groop L., Ferrannini E., Autoimmunity to CD38 and GAD in type I and type II diabetes: CD38 and HLA genotypes and clinical phenotypes Diabetologia 2002 45 9 1298 1306
104. Antonelli A., Ferri C., Fallahi P., Hepatitis C virus infection: evidence for an association with type 2 diabetes: response to Skowronski et al Diabetes Care 2006 29 3 751 (Pubitemid 44115404)
105. Antonelli A., Ferri C., Ferrari S. M., Colaci M., Sansonno D., Fallahi P., Endocrine manifestations of hepatitis C virus infection Nature Clinical Practice Endocrinology and Metabolism 2009 5 1 26 34
106. Manns M. P., McHutchison J. G., Gordon S. C., Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial The Lancet 2001 358 9286 958 965 (Pubitemid 32913521)
107. Alavian S. M., Behnava B., Tabatabaei S. V., Comparative efficacy and overall safety of different doses of consensus interferon for treatment of chronic HCV infection: a systematic review and meta-analysis European Journal of Clinical Pharmacology 2010 66 11 1071 1079
108. Kamal S. M., Fehr J., Roesler B., Peters T., Rasenack J. W., Peginterferon alone or with ribavirin enhances HCV-specific CD4 + T-helper 1 responses in patients with chronic hepatitis C Gastroenterology 2002 123 4 1070 1083
109. Yang Y. F., Tomura M., Iwasaki M., IFNalpha acts on T-cell receptor-triggered human peripheral leukocytes to up-regulate CCR5 expression on CD4 + and CD8 + T cells Journal of Clinical Immunology 2001 21 6 402 409 (Pubitemid 34017074)
110. Ning Q., Brown D., Parodo J., Cattral M., Gorczynski R., Cole E., Fung L., Ding J. W., Liu M. F., Rotstein O., James Phillips M., Levy G., Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fg12 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response Journal of Immunology 1998 160 7 3487 3493 (Pubitemid 28164743)
111. Boni C., Penna A., Ogg G. S., Bertoletti A., Pilli M., Cavallo C., Cavalli A., Urbani S., Boehme R., Panebianco R., Fiaccadori F., Ferrari C., Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy Hepatology 2001 33 4 963 971 (Pubitemid 32246646)
112. Rigopoulou E. I., Suri D., Chokshi S., Mullerova I., Rice S., Tedder R. S., Williams R., Naoumov N. V., Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: antiviral and immunological activity Hepatology 2005 42 5 1028 1036 (Pubitemid 43112669)
113. Nelson D. R., Lauwers G. Y., Lau J. Y. N., Davis G. L., Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders Gastroenterology 2000 118 4 655 660 (Pubitemid 30171614)
114. Morrow M. P., Pankhong P., Laddy D. J., Schoenly K. A., Yan J., Cisper N., Weiner D. B., Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity Blood 2009 113 23 5868 5877
115. Morrow M. P., Yan J., Pankhong P., Shedlock D. J., Lewis M. G., Talbott K., Toporovski R., Khan A. S., Sardesai N. Y., Weiner D. B., IL-28B/IFN -3 drives granzyme B loading and significantly increases CTL killing activity in macaques Molecular Therapy 2010 18 9 1714 1723
116. Pilli M., Zerbini A., Penna A., HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project) Gastroenterology 2007 133 4 1132 1143 (Pubitemid 47494444)
117. Abe H., Hayes C. N., Ochi H., IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy Journal of Hepatology 2011 54 6 1094 1101
118. Fukuhara T., Taketomi A., Motomura T., Okano S., Ninomiya A., Abe T., Uchiyama H., Soejima Y., Shirabe K., Matsuura Y., Maehara Y., Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C Gastroenterology 2010 139 5 1577 1585
119. Donnelly R. P., Dickensheets H., O'Brien T. R., Interferon-lambda and therapy for chronic hepatitis C virus infection Trends in Immunology 2011 32 9 443 4450